|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Further characterization of the expression in liver and catalytic activity of CYP 26B显示文摘 | Ekins S VandenBranden M Ring BJ | 1998 | J Pharmacol Exp Ther1998，266，： | 1 |
| 2 | The human drug metabolizing cytochromes P450显示文摘 | Wrighton SA VandenBranden M Ring BJ | 1996 | J Pharmacokinet Biopharm1996，24，5： | 1 |
| 3 | Clinical pharmacoki- netics of atomoxetine显示文摘 | Sauer JM Ring BJ Witcher JW | 2005 | Clin Pharmacokinet2005，44，6： | 1 |
| 4 | Lack of Association Between the MEF2A Gene and Myocardial Infarction显示文摘 | Wolfgang Lieb Bj?rn Mayer Inke R. K?nig Iris Borwitzky Anika G?tz Silke Kain Christian Hengstenberg Patrick Linsel-Nitschke Marcus Fischer Angela D?ring H -Erich Wichmann Thomas Meitinger Reinhold Kreutz Andreas Ziegler Heribert Schunkert Jeanette Erdmann | 2008 | Circulation2008，，2： | 1 |
| 5 | Identification of the human cytochromes P450 responsible for atomoxetine metabolism 显示文摘 | Ring BJ Gillespie JS Eckstein JA | 2002 | Drug Metab Dispos2002，30，3： | 1 |
| 6 | The human drug metabolizing cytochrome P450显示文摘 | Wrighton SA Van der Branden M Ring BJ | 1996 | J Pharmacokinet Biopharm1996，24，5： | 1 |
| 7 | Clinical pharmacokinetics of Atomoxetine显示文摘 | Sauer JM Ring BJ Witclaer JW | 2005 | Clin Pharmacokinet2005，44，6： | 1 |
| 8 | Interaction of human liver cytochromes P450 in vitro with LY307640,a gastric proton pump inhibitor显示文摘 | Vanden BM Ring BJ Binkley SN | 1996 | Pharmacoegnetics1996，6，： | 1 |
| 9 | Predic- tions of the in vivo clearance of drugs from rate of loss using human liver microsomes for phase I and phase Ⅱ biotransformations显示文摘 | Mohutsky MA Chien JY Ring BJ | 2006 | Pharm Res2006，23，4： | 1 |
| 10 | Comparative metabolic capabilities of CYP3A4, CYP3AS, and CYP3A7 显示文摘 | Williams JA Ring BJ Cantrell VE | 2002 | Drug Metab Dispos2002，30，8： | 1 |
| 11 | Comparative metabolic capabilities of CYP3M,CYP3A5 and CYP3A7显示文摘 | Williams JA Ring BJ Cantrell VE | 2002 | Drug Metab Dispas2002，30，8： | 1 |
| 12 | Comparative metabolic capabilities of CYP3A4, CYP3A5 and CYP3A7显示文摘 | Williams JA Ring BJ Cantrell VE | 2011 | Drug Metab Dispos2011，30，： | 1 |
| 13 | The human drug metabolizing cytochromes 17450 显示文摘 | Wrighton SA vardonbradon M Ring BJ | 1996 | J pharmacokinet Biopharm1996，24，5： | 1 |
| 14 | Identification of the human Cytochromes P450s responsible for atomoxetine metabo-lism 显示文摘 | Gillspie JS Eckstein A | 2002 | Drug Metabolism and Disposition2002，30，3： | 1 |
| 15 | Identification of the human cytochromes P450 responsible for atomoxetine metabo- lisin显示文摘 | Ring BJ Gillespie JS Eckstein JA | 2002 | Drug Metab Dispos2002，30，3： | 1 |
| 16 | The use of in vitro metabolism techniques in the planning and interpretation of drug safety studies显示文摘 | Wrighton SA Ring BJ VandenBranden M | 1995 | Toxicol Pathol1995，23，2： | 1 |
| 17 | Comparative metabolic capabilities of CYP3A4,CYP3A5 and CYP3A7显示文摘 | Williams JA Ring BJ Cantrell VE | 2002 | Drug Metab Dispos2002，30，： | 1 |
| 18 | Inhibition of human CYP3A catalyzed 1-hydroxy midazolam formation by ketoconazole, nifedipine, erythromycin, cimetidine, and nizatidine 显示文摘 | Wrighton SA Ring BJ | 1994 | Pharm Res1994，11，6： | 1 |
| 19 | Posterior dislocation of the elbow with fractures of the radial head and coronoid显示文摘 | RING D JUPITER JB ZILBERFAR BJ | 2002 | Bong Joint Surg2002，84，： | 1 |
| 20 | Interaction of human liver cytohhhromesP450 in vitro with LY307640,a gastric ptoton pump inhibutor显示文摘 | Vanden BM Ring BJ Binkley SN etal | 1996 | Pharmacoegnetics1996，6，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员